Eisai
4523.T
#2211
Rank
NZ$14.36 B
Marketcap
NZ$50.93
Share price
-2.15%
Change (1 day)
3.14%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2025 (TTM): NZ$1.42

According to Eisai's latest financial reports the company's current EPS (TTM) is NZ$1.50. an increase over its 2024 EPS that were of NZ$1.69.

EPS history for Eisai from 2000 to 2025

Annual EPS

Year EPS Change
2025NZ$1.8911.85%
2024NZ$1.69-32.63%
2023NZ$2.505.52%
2022NZ$2.37-74.01%
2021NZ$9.12-66.58%
2020NZ$27.2998.24%
2019NZ$13.7717.01%
2018NZ$11.7637.78%
2017NZ$8.54-27.62%
2016NZ$11.8035.33%
2015NZ$8.72-2.82%
2014NZ$8.97-27.66%
2013NZ$12.40-27.49%
2012NZ$17.10-12.67%
2011NZ$19.5988.08%
2010NZ$10.41-11.06%
2009NZ$11.71-390.15%
2008NZ-$4.04-127.78%
2007NZ$14.5311.78%
2006NZ$13.004.38%
2005NZ$12.457.4%
2004NZ$11.6043.03%
2003NZ$8.1125.09%
2002NZ$6.4852.67%
2001NZ$4.2569.76%
2000NZ$2.50